Get the Stockscreener App
0.811
1.01%
-0.0083
After Hours:
.81
-0.001
-0.12%
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Forecast
The Connect Biopharma Holdings Ltd Adr (CNTB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.9214, representing a +1,000% increase from the current price of $0.811. The highest analyst price target is $8.8912, and the lowest is $8.9517.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNTB Price Target
Average 8.618
(+962.64% Upside)
Is Connect Biopharma Holdings Ltd Adr (CNTB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.49 | Neutral |
| STOCH(9,6) | 57.74 | Neutral |
| STOCHRSI(14) | 60.44 | Neutral |
| MACD(12,26) | 0.011 | Buy |
| ADX(14) | 11.65 | Neutral |
| William %R | -30.62 | Neutral |
| CCI(14) | 72.96 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8024
Buy
|
0.7999
Buy
|
| MA20 |
0.7906
Buy
|
0.7908
Buy
|
| MA50 |
0.7468
Buy
|
0.7908
Buy
|
| MA100 |
0.8389
Sell
|
0.8492
Sell
|
| MA200 |
1.0047
Sell
|
0.9814
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, CNTB could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on CNTB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.49 indicates that CNTB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.74 indicates that CNTB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 60.44 indicates that CNTB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.65 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 72.96 indicates that CNTB is still overbought but not to an extreme extent.
Long-term CNTB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Connect Biopharma Holdings Ltd Adr financial reports and earnings history, Connect Biopharma Holdings Ltd Adr (CNTB) stock could reach $14.10 by 2030, $51.62 by 2040 and $101.02 by 2050. See the projected annual prices until 2050 of the Connect Biopharma Holdings Ltd Adr stock below:
- Connect Biopharma Holdings Ltd Adr (CNTB) is expected to reach an average price of $50.31 in 2035, with a high prediction of $49.58 and a low estimate of $50.17. This indicates an $6,103% rise from the last recorded price of $0.811.
- Connect Biopharma Holdings Ltd Adr (CNTB) stock is projected to chart a bullish course in 2040, with an average price target of $49.97, representing an $6,062% surge from its current level. The forecast ranges from a conservative $50.49 to a sky-high $51.62.
- Our analysts predict Connect Biopharma Holdings Ltd Adr (CNTB) to jump 2,450% by 2045, soaring from $21.15 to an average price of $20.68, potentially reaching $22.76. While $21.15 is the low estimate, the potential upside is significant.
- Connect Biopharma Holdings Ltd Adr (CNTB) stock is expected to climb by 2050, reaching an average of $99.65, a $12,187% jump from its current level. However, a wide range of estimates exists, with high and low targets of $101.02 and $99.87, respectively, highlighting the market's uncertainty.
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Year by Year Forecast
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2025
Connect Biopharma Holdings Ltd Adr Stock (CNTB) is expected to reach an average price of $5.3806 in 2025, with a high prediction of $10.67 and a low estimate of $0.095. This indicates an +563.45% rise from the last recorded price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $9.5912 | $8.9517 | $8.8912 | +1,083% |
| August, 2025 | $10.43 | $10.53 | $10.67 | +1,186% |
| September, 2025 | $10.18 | $10.24 | $10.32 | +1,155% |
| October, 2025 | $9.6049 | $9.6444 | $9.9349 | +1,084% |
| November, 2025 | $8.7738 | $8.9738 | $9.4892 | +981.85% |
| December, 2025 | $8.3481 | $8.4981 | $8.5487 | +929.36% |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2026
The predicted value for Connect Biopharma Holdings Ltd Adr (CNTB) in 2026 is set at an average of $6.3053. Estimates vary from a peak of $8.2373 to a trough of $4.3733, indicating an +677.47% surge from the present price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.3276 | $8.3327 | $8.193 | +926.83% |
| February, 2026 | $8.1972 | $8.2155 | $8.2373 | +910.76% |
| March, 2026 | $7.9838 | $8.0342 | $8.1139 | +884.44% |
| April, 2026 | $7.5457 | $7.5908 | $7.8363 | +830.42% |
| May, 2026 | $6.8802 | $7.0301 | $7.3478 | +748.36% |
| June, 2026 | $6.5097 | $6.5698 | $6.51 | +702.67% |
| July, 2026 | $6.134 | $6.1591 | $6.4045 | +656.35% |
| August, 2026 | $5.7634 | $5.9234 | $5.9286 | +610.66% |
| September, 2026 | $5.1777 | $5.3377 | $5.5983 | +538.44% |
| October, 2026 | $4.8672 | $5.0071 | $5.1026 | +500.15% |
| November, 2026 | $4.6166 | $4.6866 | $4.7721 | +469.25% |
| December, 2026 | $4.351 | $4.3733 | $4.4615 | +436.49% |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Connect Biopharma Holdings Ltd Adr (CNTB) is $8.1816, with a high forecast of $16.29 and a low forecast of $0.0746. This indicates an +908.83% increase from the last price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.1604 | $4.1878 | $4.2258 | +413.00% |
| February, 2027 | $3.8797 | $3.8897 | $4.0453 | +378.39% |
| March, 2027 | $3.1242 | $3.3542 | $3.7347 | +285.22% |
| April, 2027 | $2.2136 | $2.5436 | $2.709 | +172.95% |
| May, 2027 | $2.4831 | $2.211 | $2.3731 | +206.17% |
| June, 2027 | $1.9274 | $1.9624 | $2.3679 | +137.65% |
| July, 2027 | $1.5968 | $1.6668 | $1.7641 | +96.89% |
| August, 2027 | $1.1913 | $1.3213 | $1.5217 | +46.89% |
| September, 2027 | $0.7206 | $0.8406 | $1.061 | -11.15% |
| October, 2027 | $0.12 | $0.0903 | $0.8297 | -85.20% |
| November, 2027 | $15.64 | $0.0746 | $15.64 | +1,828% |
| December, 2027 | $17.02 | $16.20 | $16.29 | +1,998% |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2028
In 2028, Connect Biopharma Holdings Ltd Adr (CNTB) is projected to reach an average price of $14.39, with a high projection of $22.85 and a low estimate of $5.9217. This indicates an +1,674% rise from the last price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.73 | $17.28 | $16.25 | +2,086% |
| February, 2028 | $12.91 | $14.35 | $17.10 | +1,491% |
| March, 2028 | $5.075 | $9.075 | $11.98 | +525.77% |
| April, 2028 | $8.1039 | $9.1739 | $6.4503 | +899.25% |
| May, 2028 | $6.4825 | $7.4428 | $6.0425 | +699.33% |
| June, 2028 | $10.60 | $5.9217 | $7.0623 | +1,207% |
| July, 2028 | $12.39 | $12.86 | $11.21 | +1,428% |
| August, 2028 | $22.87 | $13.91 | $22.85 | +2,720% |
| September, 2028 | $21.50 | $22.59 | $22.11 | +2,551% |
| October, 2028 | $21.68 | $21.46 | $21.08 | +2,573% |
| November, 2028 | $21.36 | $21.06 | $21.12 | +2,533% |
| December, 2028 | $19.48 | $20.96 | $21.01 | +2,302% |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2029
The 2029 price forecast for Connect Biopharma Holdings Ltd Adr Stock (CNTB) is $18.27 on average, with a high prediction of $22.12 and a low estimate of $14.42. This represents an +2,153% increase from the previous price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.72 | $20.80 | $20.75 | +2,455% |
| February, 2029 | $22.15 | $20.85 | $22.12 | +2,631% |
| March, 2029 | $21.43 | $21.47 | $21.71 | +2,542% |
| April, 2029 | $20.67 | $20.70 | $21.09 | +2,449% |
| May, 2029 | $19.87 | $19.89 | $20.46 | +2,350% |
| June, 2029 | $18.53 | $18.66 | $19.16 | +2,184% |
| July, 2029 | $17.89 | $18.02 | $18.38 | +2,105% |
| August, 2029 | $17.56 | $17.61 | $17.74 | +2,065% |
| September, 2029 | $17.10 | $17.17 | $17.36 | +2,009% |
| October, 2029 | $16.23 | $16.25 | $16.81 | +1,901% |
| November, 2029 | $15.41 | $15.51 | $15.84 | +1,800% |
| December, 2029 | $14.35 | $14.42 | $15.10 | +1,669% |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2030
Connect Biopharma Holdings Ltd Adr Stock (CNTB) is expected to reach an average price of $10.05 in 2030, with a high forecast of $14.10 and a low forecast of $5.9957. This signifies an +1,139% surge from the last price of $0.811.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.44 | $13.63 | $14.10 | +1,557% |
| February, 2030 | $13.09 | $13.09 | $13.17 | +1,514% |
| March, 2030 | $12.30 | $12.37 | $12.87 | +1,416% |
| April, 2030 | $11.59 | $11.59 | $12.05 | +1,329% |
| May, 2030 | $10.63 | $10.88 | $11.27 | +1,211% |
| June, 2030 | $10.07 | $10.08 | $10.36 | +1,142% |
| July, 2030 | $9.3814 | $9.4114 | $9.8025 | +1,057% |
| August, 2030 | $8.8202 | $8.8225 | $9.1625 | +987.58% |
| September, 2030 | $8.1201 | $8.3143 | $8.61 | +901.25% |
| October, 2030 | $6.6361 | $7.0677 | $7.6989 | +718.26% |
| November, 2030 | $6.1167 | $5.9994 | $6.0475 | +654.21% |
| December, 2030 | $5.7818 | $5.9957 | $5.9664 | +612.92% |
0.87%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):